Organic compounds as Photosystem II inhibitors and Cu²⁺ ligands: insights from primary screening.
6 affiliations
- 1Institute of Molecular Biology, Ministry of Science and Education of the Republic of Azerbaijan, 11 Izzat Nabiev Street, AZ1073 Baku, Azerbaijan.
- 2K.A. Timiryazev Institute of Plant Physiology, Russian Academy of Sciences, 35 Botanicheskaya Street, 127276 Moscow, Russia.
- 3Institute of Basic Biological Problems, Russian Academy of Sciences, 2 Institutskaya Street, 142290 Pushchino, Moscow Region, Russia.
- 4National Research Center 'Kurchatov Institute', 1 Akademika Kurchatova Square, 123182 Moscow, Russia.
- 5Department of Chemistry, Science Faculty, Gazi University, Teknikokullar, 06500 Ankara, Turkey.
- 6Faculty of Engineering and Natural Sciences, Bahçeşehir University, Çırağan Caddesi 4-6 Osmanpaşa Mektebi, 34353 Istanbul, Turkey.
Abstract
The search for novel organic compounds as PSII inhibitors and copper (Cu²⁺) ligands addresses key agricultural challenges. Three novel compounds were synthesized and evaluated for PSII photochemical activity inhibition and Cu²⁺-chelating ability. Primary screening was performed by recording effects on minimal and maximal chlorophyll fluorescence levels in isolated thylakoids. Testing employed both direct (thylakoids + Cu²⁺ + compound) and reverse (thylakoids + compound + Cu²⁺) addition sequences, with measurements performed under short illumination (<10 s) to avoid photodynamic artifacts. The tested compounds showed no pronounced inhibitory activity toward PSII photochemistry and exhibited no strong Cu-chelating capacity. Nevertheless, these data enable formulation of more stringent structural requirements for candidate molecules and confirm the high information content of the proposed combined screening approach for further biologically active substance design.
Related
- Untargeted screening of drug-like compounds using high-throughput metabolomics uncovers inhibitors of key biological pathways
- Editorial: Biosynthesis, regulation, and ecological roles of plant volatile organic compounds
- Dynamic distribution of volatile organic compounds emitted by lilac at various developmental stages
- Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights
- Natural Compounds and Their Microbiota-Derived Metabolites as Modulators of the Microbiota–Gut–Brain Axis in Alzheimer Disease: Biochemical Mechanisms and Drug Discovery Insights—A Narrative Review
BibTeX
@article{shabanova2026organic,
title = {{Organic compounds as Photosystem II inhibitors and Cu²⁺ ligands: insights from primary screening.}},
author = {M S Shabanova and E V Zadneprovskaya and S K Zharmukhamedov and R G Vasilov and M S Karacan and S I Allakhverdiev},
journal = {Photosynthetica},
year = {2026},
month = oct,
doi = {10.32615/ps.2026.032},
url = {https://europepmc.org/article/MED/42974368},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Organic compounds as Photosystem II inhibitors and Cu²⁺ ligands: insights from primary screening.
AU - M S Shabanova
AU - E V Zadneprovskaya
AU - S K Zharmukhamedov
AU - R G Vasilov
AU - M S Karacan
AU - S I Allakhverdiev
PY - 2026
DA - 2026/10/02
JO - Photosynthetica
DO - 10.32615/ps.2026.032
UR - https://europepmc.org/article/MED/42974368
AB - The search for novel organic compounds as PSII inhibitors and copper (Cu²⁺) ligands addresses key agricultural challenges. Three novel compounds were synthesized and evaluated for PSII photochemical activity inhibition and Cu²⁺-chelating ability. Primary screening was performed by recording effects on minimal and maximal chlorophyll fluorescence levels in isolated thylakoids. Testing employed both direct (thylakoids + Cu²⁺ + compound) and reverse (thylakoids + compound + Cu²⁺) addition sequences, with measurements performed under short illumination (<10 s) to avoid photodynamic artifacts. The tested compounds showed no pronounced inhibitory activity toward PSII photochemistry and exhibited no strong Cu-chelating capacity. Nevertheless, these data enable formulation of more stringent structural requirements for candidate molecules and confirm the high information content of the proposed combined screening approach for further biologically active substance design.
SN - 0300-3604
SN - 1573-9058
ER -